by Annie De Groot | Jan 24, 2016 | Featured, News
Our latest mini-publication on ‘vaccines on demand’ can be found here: IQT Quarterly Winter 2016 – EpiVax
by Annie De Groot | Jan 21, 2016 | Featured, News, Thinking Out Loud -Blog
An academic version of this blog post, that explains why epitope redundancy provides resiliency (to bacteria) and weakness (to immune defense) can be found here. . . . So a guy named Elledge has discovered a way to test your blood for the viruses that you’ve...
by Annie De Groot | Jan 21, 2016 | Featured, News, Thinking Out Loud -Blog
An academic version of this blog post, that explains why epitope redundancy provides resiliency (to bacteria) and weakness (to immune defense) can be found here. . . . So a guy named Elledge has discovered a way to test your blood for the viruses that you’ve...
by Annie De Groot | Jun 9, 2015 | Featured, News
PROVIDENCE, RI – June 9, 2015 – The Defense Threat Reduction Agency (DTRA) is investing $5.2 Million for the development of a new type of vaccine against Q fever. Academic and industry organizations from around the world, led by Mark Poznansky of the Vaccine and...
by Annie De Groot | Apr 1, 2015 | Thinking Out Loud -Blog
Let’s Make Vaccines and Stockpile Them . . . Not! How about this for great business model – selling vaccines that are put on a shelf and have to be replaced every 4 years. Some vaccine companies make billions on that proposition. But we ask, as citizens...